Results 91 to 100 of about 493,409 (267)

A Yeast Cell Wall Derived Hybrid Hydrogel with Photothermal and Immune Combined Modality Therapy for Enhanced Anti-Melanoma Efficacy. [PDF]

Int J Nanomedicine, 2023
Yang C, Lei J, Kang X, Zhang P, Zheng S, Li Q, Zhang J.   +6 more
europepmc   +1 more source

Endoscopic Hemostatic Treatment for Acute Gastrointestinal Bleeding by Combined Modality Therapy with PuraStat and Endoscopic Hemoclips. [PDF]

Case Rep Gastroenterol, 2023
Kubo K, Hayasaka S, Tanaka I.
europepmc   +1 more source

SYSTEMATIC AND SAMPLING MEDIASTINAL LYMPH NODE DISSECTION OF COMBINED TREATMENT OF NON-SMALL CELLS LUNG CANCER IIIA(N2) STAGE

Креативная хирургия и онкология, 2017
This article  provides  results  of  combined modality  treatment of  patients with  stage IIIA(N2) non-small cells lung cancer  with systematic and selective   lymph node  dissection.
E. O. Mantsyrev, A. V. Vazhenin, O. A. Gladkov, A. A. Lukin, M. N. Mironchenko, Ya. A. Gnatiuk, S. N. Timofeev   +6 more
doaj   +1 more source

Long term remissions with combined modality therapy for advanced Hodgkin's disease [PDF]

, 1976
Leonard R. Prosnitz, Leonard R. Farber, James J. Fischer, Joseph R. Bertino, Diana Fischer   +4 more
openalex   +1 more source

Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses. [PDF]

Thorac Cancer, 2023
Shueng PW, Huang CC, Liu YM, Wu YH, Huang PI, Yen SH, Lin KH, Hsu CX.   +7 more
europepmc   +1 more source

Immune targets in the tumor microenvironment treated by radiotherapy. [PDF]

, 2019
Radiotherapy (RT), the major anti-cancer modality for more than half of cancer patients after diagnosis, has the advantage of local tumor control with relatively less systematic side effects comparing to chemotherapy.
Li, Jian Jian, Ozpiskin, Omer M, Zhang, Lu   +2 more
core  

A Randomized Phase I/II Trial to Compare Weekly Usage with Triple Weekly Usage of Paclitaxel in Concurrent Radiochemotherapy for Patients with Locally Advanced Non-small Cell Lung Cancer

Chinese Journal of Lung Cancer, 2011
Background and objective Although the guidelines of the National Comprehensive Cancer Network of USA recommend that the standard therapy for locally advanced non-small cell lung cancer (LANSCLC) is concurrent chemoradiotherapy.
Anhui SHI, Guangying ZHU, Rong YU, Yingjie WANG, Tingyi XIA   +4 more
doaj  

A Pilot Study on the Comparison of Prefrontal Cortex Activities of Robotic Therapies on Elderly with Mild Cognitive Impairment [PDF]

arXiv
Demographic shifts have led to an increase in mild cognitive impairment (MCI), and this study investigates the effects of cognitive training (CT) and reminiscence therapy (RT) conducted by humans or socially assistive robots (SARs) on prefrontal cortex activation in elderly individuals with MCI, aiming to determine the most effective therapy-modality ...
arxiv  

Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era. [PDF]

Br J Haematol, 2023
Qualls D, Imber BS, Okwali M, Hamlin PA, Kumar A, Lahoud OB, Matasar MJ, Noy A, Owens C, Zelenetz AD, North VS, Schöder H, Dogan A, Salles G, Yahalom J, Falchi L.   +15 more
europepmc   +1 more source

A brief review of low-dose rate (LDR) and high-dose rate (HDR) brachytherapy boost for high-risk prostate [PDF]

, 2019
For patients with unfavorable or high-risk prostate cancer, dose escalated radiation therapy leads to improved progression free survival but attempts to deliver increased dose by external beam radiation therapy (EBRT) alone can be limited by late ...
Baumann, Brian C, Fischer-Valuck, Benjamin W, Gay, Hiram A, Michalski, Jeff M, Patel, Sagar   +4 more
core   +1 more source